More importantly, RUP inhibited liver fibrosis not only through suppression of HSCs activation and ECM deposition but also through Hh pathway impediment as well as its anti-angiogenic effect via inhibition of HIF-1α/VEGF trajectory. The gene discussed is HIF1A; the disease is Hepatic fibrosis.